ACERAGEN INC (ACGN) Stock Price, Quote, News and Overview
NASDAQ:ACGN - Nasdaq - US00445F1093 - Common Stock - Currency: USD
ACGN Quote, Performance and Key Statistics
0.38
-0.06 (-13.83%)
The current stock price of ACGN is 0.38 USD. In the past month the price decreased by -48.99%.
ACGN Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.97 | 326.55B | ||
| AMGN | AMGEN INC | 12.81 | 142.94B | ||
| GILD | GILEAD SCIENCES INC | 12.52 | 120.65B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | N/A | 109.26B | ||
| REGN | REGENERON PHARMACEUTICALS | 11.91 | 56.98B | ||
| ARGX | ARGENX SE - ADR | 93.64 | 33.56B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.67B | ||
| ONC | BEIGENE LTD-ADR | 5.79 | 25.01B | ||
| BNTX | BIONTECH SE-ADR | N/A | 22.30B | ||
| NTRA | NATERA INC | N/A | 20.66B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.79B | ||
| BIIB | BIOGEN INC | 7.47 | 17.32B |
Related stock screener links
About ACGN
Company Profile
Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Exton, Pennsylvania and currently employs 26 full-time employees. The firm is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs. The Company’s pipeline includes ACG-701 to treat cystic fibrosis (CF) pulmonary exacerbations (PEx) and melioidosis, and ACG-801 to treat Farber disease. Its focus is to develop and optimize the commercial value of ACG-701 and ACG-801 for appropriate patients. ACG-701 is an oral, loading dose formulation of sodium fusidate being developed as a potential treatment for PEx associated with cystic fibrosis CF, a factor driving lung function decline in people living with CF. ACG-701 is also being developed for the treatment of melioidosis, a life-threatening infection that can affect numerous organ systems, including the lungs.
Company Info
ACERAGEN INC
505 Eagleview Boulevard, Suite 212
Exton PENNSYLVANIA US
Employees: 26
Phone: 14843481600.0
ACERAGEN INC / ACGN FAQ
What is the stock price of ACERAGEN INC today?
The current stock price of ACGN is 0.38 USD. The price decreased by -13.83% in the last trading session.
What is the ticker symbol for ACERAGEN INC stock?
The exchange symbol of ACERAGEN INC is ACGN and it is listed on the Nasdaq exchange.
On which exchange is ACGN stock listed?
ACGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ACERAGEN INC stock?
7 analysts have analysed ACGN and the average price target is 17.34 USD. This implies a price increase of 4463.16% is expected in the next year compared to the current price of 0.38. Check the ACERAGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ACERAGEN INC worth?
ACERAGEN INC (ACGN) has a market capitalization of 3.20M USD. This makes ACGN a Nano Cap stock.
How many employees does ACERAGEN INC have?
ACERAGEN INC (ACGN) currently has 26 employees.
Should I buy ACERAGEN INC (ACGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACGN, evaluating the profitability, health, valuation and growth aspects
- ACERAGEN INC (ACGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACERAGEN INC (ACGN) Sales and EPS estimates to see what analysts future expectations are.
- ACERAGEN INC (ACGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACERAGEN INC (ACGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACERAGEN INC (ACGN) Stock Chart to make your own analysis
- ACERAGEN INC (ACGN) Latest news and press-releases to stay up to date.
Does ACERAGEN INC (ACGN) stock pay dividends?
ACGN does not pay a dividend.
When does ACERAGEN INC (ACGN) report earnings?
ACERAGEN INC (ACGN) will report earnings on 2023-11-13, after the market close.
ACGN Technical Analysis
ACGN Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ACGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ACGN. The Buy consensus is the average rating of analysts ratings from 7 analysts.